IUC24396-89

Abstract Code: IUC24396-89 The fate of the hydronephrotic kidney in muscle-invasive bladder cancer. M. Gami 1, T. Rich 1, H. Motiwala 1 (1) Southend University Hospital, Essex, UK. – United Kingdom   Background: Hydronephrosis is an independent predictor of...

IUC24392-85

Abstract Code: IUC24392-85 Real-world use of erdafitinib in urothelial carcinoma: an Italian multicenter retrospective study A. Dri 1, A. Polymeropoulos 2, E. Lai 3, F. Pierantoni 3, M. Ghidini 4, A. Mennitto 5, A. Zivi 6, E. Tassinari 7, R. Cengarle 8, L. Fratino 1...

IUC23438-85

Abstract Code: IUC23438-85 Clinico-pathological profile of Bladder cancer patients in a Tertiary care Centre. O.V. Potdar 1 (1) MUMBAI – India Introduction: Bladder cancer (BC) is one of the most common urological malignancies. With Industrialisation, increasing...

IUC24434-82

Abstract Code: IUC24434-82 Real-World Use of Abiraterone and Olaparib in Metastatic Castration-Resistant Prostate Cancer (mCRPC): A Two-Centre UK Experience M.  Ali Hassan 1, J. Kadamala Samuel 2, M. Maffezzoli 3, N. Kolambil Saidalavi 3, R. Arora 3, S. Sandulache 3,...

IUC24433-81

Abstract Code: IUC24433-81 Docetaxel versus olaparib plus abiraterone as first-line treatment in patients with mCRPC: a retrospective single-centre analysis M.  Maffezzoli 1, L. Pedapati 1, M. Hassan 1, S.A. Sandulache 1, J. Samuel 1, F. Di Costanzo 2, G. Neola 3, J....
error: Content is protected !!